Role of Leptin in Systemic Lupus Erythematosus
Role of Leptin in Systemic Lupus Erythematosus
批准号:
7146995
负责人:
ANTONIO LA CAVA
金额:
$33.99万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-08-01 至 2011-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Leptin is a hormone primarily involved in the regulation of basal metabolism and with an important role in immune responses. Leptin promotes inflammation and can accelerate onset and progression of several autoimmune diseases in mice. We have preliminary data that suggest that leptin may also play a role in the pathogenesis of murine and human systemic lupus erythematosus (SLE). Because of that, we will dissect the immune effects of leptin on human SLE and will test new possibilities of leptin-based intervention in SLE. Since we hypothesize that leptin affects the phenotype and function of immune-cell subsets and promotes the release of soluble mediators in order to exert its pro-pathogenic effects in SLE, we will study several cellular aspects (phenotype, function) and molecular events (cell signaling) induced by leptin in human SLE. We will then test different approaches of leptin-based therapeutic intervention in SLE using different leptin antagonists, first in vitro and then in vivo, to ultimately set the stage for translation studies to humans. In parallel, we will do genetic association studies to address whether leptin-related polymorphisms in SLE can contribute to a predisposing background by modulating leptin levels or responsiveness to leptin. By defining some crucial aspects related to the physiopathology of leptin in SLE, these studies will explore new strategies of therapeutic intervention for SLE that may ultimately lead to improved management of the disease. LAY DESCRIPTION OF THE PROJECT: Leptin is a hormone that controls several functions in humans, including immune responses. We have preliminary data that suggest that leptin can play an important role in the development and progression of systemic lupus erhytematosus, an incurable disease that is characterized by systemic effects and by the production of antibodies to self components that cause irreversible kidney damage. This study will detail the effects of leptin on human lupus and compare the potential of different leptin-based approaches with the goal to improve the current therapeutic management of human lupus.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Autoantibody blockade in neonatal lupus
-
批准号:10170280
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2020
-
负责人:ANTONIO LA CAVA
-
依托单位:
Antibody-mediated suppression of autoimmunity in humanized mice
-
批准号:9895546
-
项目类别:
-
资助金额:$16.25万
-
财政年份:2019
-
负责人:ANTONIO LA CAVA
-
依托单位:
Sexual Dimorphism and Dysregulated Immune Responses in SLE: The Role of Leptin
-
批准号:8178630
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2011
-
负责人:ANTONIO LA CAVA
-
依托单位:
Sexual Dimorphism and Dysregulated Immune Responses in SLE: The Role of Leptin
-
批准号:8321506
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2011
-
负责人:ANTONIO LA CAVA
-
依托单位:
Role of Leptin in Systemic Lupus Erythematosus
-
批准号:7648189
-
项目类别:
-
资助金额:$32.34万
-
财政年份:2006
-
负责人:ANTONIO LA CAVA
-
依托单位:
Role of Leptin in Systemic Lupus Erythematosus
-
批准号:7270077
-
项目类别:
-
资助金额:$33.0万
-
财政年份:2006
-
负责人:ANTONIO LA CAVA
-
依托单位:
Role of Leptin in Systemic Lupus Erythematosus
-
批准号:7456425
-
项目类别:
-
资助金额:$32.34万
-
财政年份:2006
-
负责人:ANTONIO LA CAVA
-
依托单位:
Role of Leptin in Systemic Lupus Erythematosus
-
批准号:7876917
-
项目类别:
-
资助金额:$32.02万
-
财政年份:2006
-
负责人:ANTONIO LA CAVA
-
依托单位:
Leptin-based intervention in systemic autoimmunity
-
批准号:6863804
-
项目类别:
-
资助金额:$19.28万
-
财政年份:2005
-
负责人:ANTONIO LA CAVA
-
依托单位:
Leptin-based intervention in systemic autoimmunity
-
批准号:7038254
-
项目类别:
-
资助金额:$22.63万
-
财政年份:2005
-
负责人:ANTONIO LA CAVA
-
依托单位:
国内基金
海外基金
登录
查看更多内容
靶向Human ZAG蛋白的降糖小分子化合物筛选以及疗效观察
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:胡文静
-
依托单位:
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
-
批准号:82370885
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨
-
依托单位:
自闭症相关基因CHD8在非人灵长类大脑发育中的作用
-
批准号:32100783
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:赵晖
-
依托单位:
HBV S-Human ESPL1融合基因在慢性乙型肝炎发病进程中的分子机制研究
-
批准号:81960115
-
项目类别:地区科学基金项目
-
资助金额:34.0万元
-
批准年份:2019
-
负责人:江建宁
-
依托单位:
HPV导致子宫颈上皮-间充质细胞转化的研究
-
批准号:81101974
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:江静
-
依托单位:
普适计算环境下基于交互迁移与协作的智能人机交互研究
-
批准号:61003219
-
项目类别:青年科学基金项目
-
资助金额:7.0万元
-
批准年份:2010
-
负责人:沈耀
-
依托单位:
DARC在基底细胞样乳腺癌中作用机制的研究
-
批准号:81001172
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:王杰
-
依托单位:
基于自适应表面肌电模型的下肢康复机器人“Human-in-Loop”控制研究
-
批准号:61005070
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:李庆玲
-
依托单位:
子宫颈癌中HPV E6对hTERT基因调控的研究
-
批准号:81001157
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2010
-
负责人:赵超
-
依托单位:
人真皮多潜能成纤维细胞向胰岛素分泌细胞分化的体外及体内研究
-
批准号:30800231
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2008
-
负责人:陈付国
-
依托单位: